|
Age, years, mean (range)
|
75 (50–89)
|
253
|
|
Male, n (%)
|
141 (56%)
|
253
|
|
Comorbidity, n (%):
| | |
|
Diabetes
|
63 (25%)
|
253
|
|
Hyperlipidemia
|
96 (38%)
|
253
|
|
Hypertension
|
162 (64%)
|
253
|
|
Previous AMI
|
37 (15%)
|
253
|
|
Previous stroke
|
32 (13%)
|
253
|
|
Aspirin use, n (%)
|
102 (40%)
|
253
|
|
Oral anticoagulant drug use*, n (%)
|
18 (7%)
|
253
|
|
Total iNPH scale score, mean (SD)
|
49.8 (19.0)
|
253
|
|
Separate domain scores, mean (SD)
| | |
|
Balance domain
|
64.3 (20.9)
|
244
|
|
Continence domain
|
59.5 (26.1)
|
246
|
|
Gait domain
|
38.9 (24.1)
|
253
|
|
Cognitive domain
|
48.9 (21.2)
|
98
|
|
MMSE score, median (IQR)
|
25.0 (22.0–28.0)
|
249
|
|
Time between preoperative evaluation and surgery, months, median (IQR)
|
6 (4–8)
|
253
|
|
Protein concentrations, ng/L, median (IQR)
| | |
|
T-tau
|
211 (150–326)
|
240
|
|
P-tau
|
30 (23–39)
|
236
|
|
Aβ1-42
|
540 (378–708)
|
237
|
|
NfL
|
1200 (790–1730)
|
75
|
